tetradecanoylphorbol acetate has been researched along with Parkinson Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Badri, G; Castorina, A; Karunia, J; Keay, KA; Mandwie, M; Musumeci, G; Niaz, A | 1 |
| Feng, Y; He, ZY; Liu, L; Luo, XG; Ren, Y; Shang, H; Yin, YF; Yu, HM | 1 |
| Boldyrev, AA; Bychkova, ON; Tuneva, EO | 1 |
| Imamura, K; Nagatsu, T; Sawada, M | 1 |
| Carreras, MC; Gatto, EM; Pargament, GA; Poderoso, JJ; Riobó, NA; Schöpfer, FJ | 1 |
1 review(s) available for tetradecanoylphorbol acetate and Parkinson Disease
| Article | Year |
|---|---|
Role of cytokines in inflammatory process in Parkinson's disease.
Topics: Animals; Cytokines; Hippocampus; Humans; Inflammation; Microglia; Neostriatum; Parkinson Disease; Putamen; Substantia Nigra; Tetradecanoylphorbol Acetate | 2006 |
4 other study(ies) available for tetradecanoylphorbol acetate and Parkinson Disease
| Article | Year |
|---|---|
Robust Dopaminergic Differentiation and Enhanced LPS-Induced Neuroinflammatory Response in Serum-Deprived Human SH-SY5Y Cells: Implication for Parkinson's Disease.
Topics: Cell Line, Tumor; Cellular Reprogramming Techniques; Culture Media, Serum-Free; Dopaminergic Neurons; Humans; Lipopolysaccharides; Neurogenesis; Nitric Oxide Synthase Type I; Parkinson Disease; Plasminogen Activator Inhibitor 1; Proto-Oncogene Proteins c-akt; Tetradecanoylphorbol Acetate | 2021 |
Repeated intra-nigrostriatal injection of phorbol myristate acetate induces microglial senescence in adult rats.
Topics: Animals; Carcinogens; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p21; Drug Evaluation, Preclinical; Injections, Intraventricular; Male; Microglia; Parkinson Disease; Rats, Sprague-Dawley; Substantia Nigra; Tetradecanoylphorbol Acetate | 2015 |
Effect of NMDA on production of reactive oxygen species by human lymphocytes.
Topics: Humans; Luminescent Measurements; Lymphocytes; N-Methylaspartate; Parkinson Disease; Reactive Oxygen Species; Tetradecanoylphorbol Acetate | 2003 |
Circulating plasma factors in Parkinson's disease enhance nitric oxide release of normal human neutrophils.
Topics: Female; Humans; Hydrogen Peroxide; Male; Middle Aged; Neutrophils; Nitric Oxide; Parkinson Disease; Stimulation, Chemical; Tetradecanoylphorbol Acetate | 1999 |